Clinical Trials Directory

Trials / Completed

CompletedNCT00643149

A Multicenter, Randomized, Double-Blind, Double-Dummy Study Of Azithromycin SR Versus Amoxicillin For The Treatment Of Strep Throat In Children

A Multicenter, Randomized, Double-Blind, Double-Dummy Comparative Trial Of Azithromycin SR Versus Amoxicillin For The Treatment Of Group A Β-Hemolytic Streptococcal Pharyngitis/Tonsillitis In Children

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
693 (actual)
Sponsor
Pfizer · Industry
Sex
All
Age
2 Years – 12 Years
Healthy volunteers
Not accepted

Summary

The objective was to determine if a single 60 mg/kg dose of azithromycin SR was as safe and effective as a 10-day regimen of amoxicillin (45 mg/kg/day, given in divided doses every 12 hours) when used to treat children with strep throat.

Conditions

Interventions

TypeNameDescription
DRUGamoxicillin10 day regimen, 45 mg/kg/day, given in divided doses every 12 hours
DRUGazithromycin SR60 mg/kg dose of azithromycin SR was as safe and effective as a 10-day regimen of amoxicillin when used to treat children with strep throat

Timeline

Start date
2003-05-01
Completion
2004-03-01
First posted
2008-03-26
Last updated
2011-05-17

Locations

46 sites across 5 countries: United States, Canada, Costa Rica, Guatemala, India

Source: ClinicalTrials.gov record NCT00643149. Inclusion in this directory is not an endorsement.